HOME >> BIOLOGY >> NEWS
Wistar Scientist Awarded US Army Prostate Cancer Research Program Grant

Philadelphia -- George C. Prendergast, Ph.D., a scientist in The Wistar Institute's Molecular Genetics Program, has been awarded a $491,000 US Army Prostate Cancer Research Program grant for research into a possible new diagnostic and prognostic marker for prostate cancer.

An intriguing set of data accumulated in Dr. Prendergast's laboratory suggests that a new prostate cancer suppressor gene, called Bin1, may accumulate in aggressive malignant cells but not in non-threatening or normal prostate cells. "If that is true," explains Dr. Prendergast, "Bin1 could be a molecular marker that identifies aggressive cancers of the prostate and makes it possible to predict the risk of each prostate cancer patient."

Bin1 was discovered because of its ability to interact with and inhibit the transforming potential of Myc, a cancer causing protein that is often activated in a wide variety of human cancers, including prostate carcinoma. Myc is of particular interest because it not only promotes malignant cell growth, but also, under certain conditions, can activate cell suicide.

"We identified Bin1 as part of an effort to learn how this Myc 'booby trap' might be sprung in cancer cells to kill them," says Dr. Prendergast. "Our recent results support our hypothesis that Bin1 controls Myc's killing activity."

The Wistar Institute, established in 1892, was the first independent medical research facility in the country. For more than 100 years, Wistar scientists have been making history and improving world health through their development of vaccines for diseases that include rabies, German measles, infantile gastroenteritis (rotavirus), and cytomegalovirus; discovery of molecules like interleukin-12, which are helping the immune system fight bacteria, parasites, viruses and cancer; and location of genes that contribute to the development of diseases like breast, lung and prostate cancer. Wistar is a National Cancer Institute Cancer Center.


'"/>

Contact: Diana Cutshall
dcutshall@wista.wistar.upenn.edu
(215) 898-3716
The Wistar Institute
20-May-1998


Page: 1

Related biology news :

1. Wistar-discovered antibody will help diagnose appendicitis
2. 2004 Wistar Institute Science Journalism Award winners announced
3. Call for Entries: The 2004 Wistar Institute Science Journalism Award
4. Wistar-developed antibody shows promise against brain tumors in Drexel trial
5. Wistar study offers new support for a histone code theory of gene regulation
6. Regeneration in the mammalian heart demonstrated by Wistar researchers
7. Wistar scientists add difficult-to-sequence stretches to human genome data
8. Wistar scientist receives award from National Cancer Institute
9. Director of Emory Vaccine Center to give Wistar Institutes 1999 Tadeusz J. Wiktor Memorial lecture
10. Wistar scientists find striking similarities between bacterial virus and human adenovirus
11. Wistar Institute scientists find key piece in gene regulation puzzle

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2019)... ... January 07, 2019 , ... Franz ... Graph Database technology for Knowledge Graphs solutions, announced that it was recognized by ... . DBTA’s data and information management recognition list includes newer approaches leveraging ...
(Date:12/27/2018)... BOSTON (PRWEB) , ... December 27, 2018 , ... ... first 60 cervical discs for implantation at its new Boston facility, and is ... to have additional inventory to immediately expand market share against inferior ball and ...
(Date:12/19/2018)... ... 2018 , ... NDA Partners Chairman Carl Peck, MD, announced today that ... for Devices and Radiological Health (CDRH), has been appointed a Partner in the firm. ... she has more than 25 years of regulatory experience. In addition to her FDA ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/4/2019)... ... January 04, 2019 , ... ... Ted Hoffman to the firm. Ted will be joining the firm as a ... and providing consulting services to the pharmaceutical industry. At Triangle Insights, Ted will ...
(Date:12/19/2018)... ... December 19, 2018 , ... R3 Stem Cell is ... Training Course in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile ... nationwide for aesthetics, having the training from expert, Board Certified providers is critical ...
(Date:12/14/2018)... ... December 14, 2018 , ... NOVA OCULUS ... given the green light to immediately begin a clinical patient trial in Edmonton ... devices bureau of Health Canada has granted what is called an Investigational Testing ...
Breaking Biology Technology:
Cached News: